FilingSEC EDGAR8-K
Benitec Biopharma Appoints EY as New Independent Auditor
· SEC accepted
StageAuditor Change
Filing content
The company dismissed Baker Tilly and appointed EY as its new independent registered public accounting firm as part of corporate governance improvements. The formal engagement is subject to EY's client acceptance process.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…